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The human gut harbors diversemicrobes that play a fundamental role in thewell-being of their host.
The constituents of the microbiota—bacteria, viruses, and eukaryotes—have been shown to
interact with one another and with the host immune system in ways that influence the development
of disease.We review these interactions and suggest that a holistic approach to studying themicro-
biota that goes beyond characterization of community composition and encompasses dynamic
interactions between all components of the microbiota and host tissue over time will be crucial
for building predictive models for diagnosis and treatment of diseases linked to imbalances in
our microbiota.Introduction
We have only recently started to appreciate that the human
body is home to far more than human cells: we harbor at least
100 trillion (1014) microbial cells (Whitman et al., 1998) and a
quadrillion viruses in and on us (Haynes and Rohwer, 2011).
Collectively, the microbial associates that reside in and on the
human body constitute our microbiota, and the genes they
encode is known as our microbiome. This complex community
contains taxa from across the tree of life, bacteria, eukaryotes,
viruses, and at least one archaeon, that interact with one another
and with the host, greatly impacting human health and physi-
ology. Only a small minority of these can be cultured, and
recently, culture-independent high-throughput sequencing has
greatly expanded the repertoire of known microbes both in our
bodies and in the environment (Shendure and Ji, 2008; Whitman
et al., 1998). Highly multiplexed studies have made it possible
to characterize and compare many samples rapidly (Caporaso
et al., 2010; Hamady et al., 2008), enabling the detection of
spatial, temporal, and disease-associated patterns in our
microbiota.
The microbiota plays a major role in health and disease in
humans; indeed, it is sometimes referred to as our ‘‘forgotten
organ’’ (O’Hara and Shanahan, 2006). The microbiota is involved
in energy harvest and storage, as well as in a variety of metabolic
functions such as fermenting and absorbing undigested carbo-
hydrates (Gill et al., 2006), a trait that has probably acted as
a strong evolutionary force toward the establishment of bacteria
as human symbionts. Perhaps even more importantly, the gut
microbiota interacts with the immune system, providing signals
to promote the maturation of immune cells and the normal
development of immune functions (Chow et al., 2010).
In this Review, we give an overview of the current under-
standing of the microbiota and its development in healthy indi-
viduals. To further characterize this ‘‘healthy microbiota,’’ we
also describe the interactions that typically occur in the human1258 Cell 148, March 16, 2012 ª2012 Elsevier Inc.gut between viruses, eukaryotes, bacteria, and the host immune
system. We then discuss how imbalances in the composition of
the microbiota, and the induced changes in interactions with the
host, relate to diseases such as obesity or Crohn’s disease. In
each section we highlight lessons that have been learned about
various interacting parts of the microbiota and argue that adopt-
ing an integrated perspective will foster a deeper understanding
of the many diseases that are related to disruption of the micro-
biota and lead to microbiota-based therapeutic options for
treating these diseases. Finally, we detail the findings of some
recent studies that do present an integrated view of the human
microbiota in the context of human health and disease.
The Healthy Microbiota
Characterizing the Human Gut Microbiota:
Who Is in There?
Determining what constitutes a healthy microbiota and the vari-
ability found across populations is a prerequisite for assessing
deviations that are associated with disease states. Microbes
colonize all of the surfaces of the human body that are exposed
to the environment, with the majority residing in the intestinal
tract, which is the focus of this Review. Distinct microbial
communities are also found in the mouth (Nasidze et al., 2009),
in the vagina (Ravel et al., 2011), and on the skin (e.g., Costello
et al., 2009; Grice et al., 2009). Bacterial communities in a given
body site resemble themselves more than those in different body
sites, i.e., the oral bacterial communities across individuals are
more similar than those of the skin and mouth of an individual
(Costello et al., 2009). At each body site there is also consider-
able interindividual variability (Costello et al., 2009; Robinson
et al., 2010).
The bacterial component of the microbiota has been the
subject of intensive study in recent years, driven by large-scale
projects such as the Human Microbiome Project (Peterson
et al., 2009; Turnbaugh et al., 2007) and MetaHIT (Qin et al.,
2010). These studies have demonstrated a large variability in the
composition of the community in healthy individuals, with twins
sharing less than 50% of their species-level bacterial taxa
(Turnbaugh et al., 2010) and even fewer viral sequences (Reyes
et al., 2010). The factors that shape community composition
are beginning to be understood. Host genetics play an important
role in the establishment and shaping of the gut microbiota, as it
has been demonstrated that composition of the bacterial
community is influenced by specific host genomic loci (Benson
et al., 2010; Spor et al., 2011), although this is not the case for
viral communities (Reyes et al., 2010). Metagenomic studies
have established that despite the extensive interpersonal
variability in community composition, there is a shared core of
functionalities in the microbiome (Burke et al., 2011; Turnbaugh
et al., 2009a). Building upon this knowledge, the literature char-
acterizing the microbiota (or at least the bacterial component) in
disease is exploding (Table 1) (Pflughoeft and Versalovic, 2011).
The gut microbiota is typically dominated by bacteria and
specifically by members of the divisions Bacteroidetes and
Firmicutes (Turnbaugh et al., 2006). Although there is a huge
range of variation in the taxa present in the gut and interindividual
variability in microbial composition, it has been suggested that
the microbiota of most individuals can be categorized into one
of three variants or ‘‘enterotypes’’ based on the dominant genera
(Bacteroides, Prevotella, or Ruminococcus) (Arumugam et al.,
2011). These clusters may in fact be more appropriately charac-
terized as a ratio of the abundance ofBacteroides andPrevotella,
with the Ruminococcus enterotype folded into the Bacteroides
group (Wu et al., 2011). These broad patterns are driven primarily
by dietary effects (Wu et al., 2011); it remains to be seen how
important they are in understanding overall community function.
Knowledge about bacterial communities far outpaces that of
viral and eukaryotic communities, although these agents are
known causes of many disease states in the gut. In our discus-
sions, we take a broad view of eukaryotes and viruses, including
fungi and microbial lineages within eukaryotes and bacterio-
phages among the viruses. The eukaryotes and viruses that
are associated with humans have typically been studied with
a focus on specific pathogenic organisms (Bogitsh et al., 2005;
Collier et al., 2011). However, increasing attention is being paid
to elucidating the eukaryotic component of the microbiota
(Ghannoum et al., 2010; Scanlan and Marchesi, 2008), and
recent research is beginning to show that even healthy humans
harbor a diverse consortium of viruses that make up the human
virome (Breitbart et al., 2008; Haynes and Rohwer, 2011; Virgin
et al., 2009). Most viral sequences currently being identified in
mammals are novel, suggesting that we are just beginning to
characterize the diversity within the human virome (Breitbart
et al., 2008; Haynes and Rohwer, 2011; Virgin et al., 2009).
This is likely an underestimate of total viral diversity, as nucleic
extraction methods are known to be biased toward encapsu-
lated viruses. Similar to gut bacteria, interpersonal variation in
the virome is high (Minot et al., 2011; Reyes et al., 2010). The
initial microbial eukaryotes found associated with the microbiota
will likely be those known from parasitology, such asGiardia and
Entamoeba, that can be identified through culture-independent
microscopy methods. Elucidating the variability in community
composition across individuals awaits comprehensive studiesof geographically diverse populations. Changing the focus
from individual agents that are implicated in disease toward
a community view has already precipitated paradigm shifts in
the view of the virome and disease (Virgin et al., 2009), and the
same will likely be true for eukaryotic microbes.
Temporal Dynamics of the Microbiota
Initial work aimed at enumerating and categorizing human-
associated microbial organisms (Costello et al., 2009; Eckburg
et al., 2005; Ley et al., 2005) has been complemented by studies
that describe the temporal dynamics of bacterial communities
(Caporaso et al., 2011). Understanding the stability of the micro-
biota within an individual through time is an important step in
enabling prediction of disease states and developing therapies
to correct dysbiosis (imbalances in the microbial community).
Time series data show that the composition of the microbiota
is relatively stable within healthy adult individuals over time for
bacteria (Caporaso et al., 2011; Costello et al., 2009), viruses
(Reyes et al., 2010), and eukaryotes (Scanlan and Marchesi,
2008). However, this temporal consistency assumes that
numerous variables, including diet, disease, and environment,
are also being held constant.
Dietary changes in particular have been shown to have signif-
icant effects on the microbiota. For example, once established,
the healthy adult human virome seems to be relatively stable,
with >95% of viral sequences showing minimal variation over
a time period of 1 year (Reyes et al., 2010). However, Minot
et al. have recently shown that the viromes of healthy adults
can converge to a more similar state due to dietary intervention
(Minot et al., 2011). Additionally, it has been shown in mice that
shifting to a high-fat, high-sugar ‘‘Western’’ diet from a low-fat,
plant polysaccharide-rich diet can change the microbiota within
a day (Turnbaugh et al., 2009b). In another study in humans,
shifting from a high-fat/low-fiber diet to a low-fat/high-fiber diet
caused notable changes in the gut microbiota within 24 hr (Wu
et al., 2011). Interestingly, diet also correlates with enterotype,
as individuals on a diet high in animal fat have a Bacteroides-
dominated enterotype, whereas a carbohydrate-rich diet is
associated with the Prevotella-dominated enterotype (Wu
et al., 2011).
These longitudinal studies allow us to differentiate transient
microbes that generally originate from the environment from
permanent members of the microbiota and elucidate differences
in the host interactions between these two populations. These
studies have provided a baseline characterization of the vari-
ability of the gut microbial composition, laying the foundation
for future studies to be able to detect differences in the micro-
biota that are characteristic of disease states and to be better
able to predict these states.
Establishment of the Microbiota
As we develop and change from infancy to old age, so does our
microbiota. In contrast to the studies described above, where
either the timescale is relatively short or the subjects are already
adults, work on the initial colonization of the intestinal tract of
infants has opened a window into the succession dynamics of
the gut (Figure 1). Traditionally babies have been considered
sterile in utero and thus present a blank canvas for colonization
by microbiota at each generation. There is countervailingCell 148, March 16, 2012 ª2012 Elsevier Inc. 1259
Table 1. Changes in the Gut Microbiota Associated with Disease
Implicated Microbiotaa Changes in Microbiota Presence/Function Referencesb
Allergies
Lactobacillus spp. Y early colonization with Lactobacillus associated w/decreased allergies Round et al., 2011
Bifidobacterium adolescentis Y early colonization with more diverse microbiota
might prevent allergies
Round and Mazmanian, 2009
Clostridium difficile Y
Helicobacter pylori Y H. pylori tolerance mediated by Tregs that suppress asthma Arnold et al., 2011
Celiac’s disease
Bacteroides vulgatus [ higher diversity (Shannon-Wiener index) in
Celiac’s disease patients versus controls
Elinav et al., 2011
Escherichia coli Y
Clostridium coccoides Y
Gastric Cancer
H. pylori [ important element in carcinogenic pathway for developing gastric
adenocarcinomas
Lathrop et al., 2011
Austim
Bacteroidetes [ increased bacterial diversity in feces of autistic children compared
to controls
Robinson et al., 2010
Proteobacteria [
Actinobacteria Y
Firmicutes Y
Obesity
Bacteroidetes Y significant changes in gut microbiota are associated with
increasing obesity
Ley et al., 2005; Pflughoeft and
Versalovic, 2011Lactobacillus [
Firmicutes/Bacteroidetes ratio Y Ley et al., 2005
Methanobrevibacter smithii Y Turnbaugh et al., 2009b
Anorexia
Methanobrevibacter smithii [ Bacteroidetes, Firmicutes, and Lactobacillus similar to
lean patients, though M. smithii significantly increased
Armougom et al., 2009;
Pflughoeft and Versalovic, 2011
IBD—Crohn’s Disease
Bacteroides ovatus [ less diversity in patients with Crohn’s disease compared to
healthy patients
Dicksved et al., 2008
Bacteroides vulgatus [
Bacteroides uniformis Y
IBD (General)
Bacteroidetes Y IBD associated with overall community dysbiosis rather
than single causal bacterial species
Spor et al., 2011;
Perry et al., 2006Lachnospiraceae Y
Actinobacteria [
Proteobacteria [
Clostridium leptum Y
Clostridium coccoides Y
Faecalibacterium prasnitzii Y
Firmicutes/Bacteroidetes ratio Y
Bifidobacteria Y
Type 2 Diabetes
Firmicutes Y shifts in gut microbiota associated with increases in plasma
glucose concentrations
Brown, 2000
Clostridia Y
Bacteroides-Prevotella [ versus
Clostridia coccoides-Eubacterium
rectale Y
Betaproteobacteria [
Bacteroidetes/Firmicutes ratio [
aChanges relative to healthy subjects. Increase: [. Decrease: Y.
bReferences are exemplary rather than exhaustive and focus on studies that compare healthy versus diseased individuals.
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Figure 1. Development of the Microbiota
The gastrointestinal tract of the fetus is sterile until birth, after which the newborn is initially colonized. Depending on delivery mode, the initial communities tend
toward a skin-like (caesarean section) or a vaginal-like (vaginal delivery) configuration. During the first weeks of life, there is a reduced activity of TLRs, potentially
allowing the necessary formation of a stable bacterial community in the gut. As the infant grows, and with the introduction of solid foods, the microbiota diversity
increases, and the community converges toward an adult-like state. At the same time, the immune system ‘‘learns’’ to differentiate between commensal and
pathogenic bacteria. By adulthood, a relatively stable community composition (but varying between different individuals) is achieved, dominated mostly by
Bacteroidetes and Firmicutes. Different diseases are characterized by significant changes in the microbiota and associated changes in the production of
cytokines.evidence that there are bacteria present in amniotic fluid in utero
even in healthy neonates (Jime´nez et al., 2008), but regardless
both number and diversity of microbes are low. The earliest
infant stool sample, the meconium, is free of detectable viral
particles (Breitbart et al., 2008) and harbors very low diversity
of bacteria (Koenig et al., 2011). Babies are exposed to a plethora
of microbes from different environments immediately upon birth
and are rapidly colonized by the microbes they first encounter,
either from their mother’s vagina or from skin microbes, depend-
ing on delivery mode (Figure 1) (Adlerberth and Wold, 2009;
Dominguez-Bello et al., 2010). Infants born vaginally have
communities resembling those found in the vaginal microbiota
of their mothers. In contrast, those delivered by caesarean
section harbor a microbiota characteristic of skin and dominated
by taxa such as Staphylococcus and Propionibacterium spp.
(Dominguez-Bello et al., 2010). Delivery mode has also been
hypothesized to influence immunological functions during the
first year of life via gut microbiota development, with babies
delivered by caesarean section having lower bacterial cell
counts in fecal samples and a higher number of antibody-
secreting cells (Huurre et al., 2008).
Evolving Development of the Microbiota
The diversity of both bacteria and viruses in the infant gut is
initially very low, then climbs through early development (Adler-
berth and Wold, 2009; Breitbart et al., 2008; Koenig et al.,2011; Vaishampayan et al., 2010). Early colonizers are generally
aerotolerant, as the gut initially contains oxygen, and then are re-
placed by anaerobes that are typical of the adult gut microbiota
(Palmer et al., 2007). One study found that the virome changes
quickly, as a majority of the sequences (56%) found in the first
week of like were not present after the second week, and the
repertoire expands rapidly in diversity and number over the first
3 months (Breitbart et al., 2008). This contrasts with the stability
seen in adults where 95% of viral types are conserved over time
(Reyes et al., 2010). Viral particles were not found in the formula
or breast milk, although transmission of specific viruses, such as
HIV, is known to occur via this route. Overall, this suggests that
the infant is predominately acquiring these viral particles through
environmental and maternal contact (Breitbart et al., 2008).
These initial colonizers are replaced by phylotypes that by
11 months are specific to the infant and different from those
found in the mother (Vaishampayan et al., 2010), although
deeper sequencing might reveal that some of the initial taxa
are present at abundances below the current detection
threshold. A detailed time series of a single infant demonstrates
that phylogenetic diversity increases gradually over time (Koenig
et al., 2011). This pattern is punctuated by major shifts in taxo-
nomic composition of the microbiota associated with life events
such as antibiotic use and the introduction of solid foods (Koenig
et al., 2011). The extent to which this added diversity developsCell 148, March 16, 2012 ª2012 Elsevier Inc. 1261
from the initial inoculum or comes from ongoing exposure to
parents, diet, other environmental sources, etc. remains an
exciting area of study as quantitative estimates are not yet
available.
Metagenomic analysis revealed how the microbiome is en-
riched early in life in genes to facilitate lactate utilization when
the infant’s diet is breast milk and formula (Koenig et al., 2011).
The microbiome of infants harbors the functionality found in
mothers despite having a different taxonomic composition
(Vaishampayan et al., 2010). Most interestingly, the functional
capacity to utilize plant-derived glycans is present before the
introduction of solid food, suggesting that the infant gut is ready
to switch to a diet not exclusively based onmilk before the actual
change in diet takes place (Koenig et al., 2011). The bacterial
composition begins to converge toward an adult-like microbiota
by the end of the first year of life (Palmer et al., 2007) and fully
resembles the adult microbiota by 2.5 years of age (Koenig
et al., 2011). Once themicrobiota has reachedmaturity it remains
mostly stable until old age. The ELDERMET consortium studied
themicrobiota of the elderly, finding a characteristic composition
different from that of young adults, particularly in the proportions
of Bacteroides spp. and Clostridium groups (Claesson et al.,
2011). Variability in community composition is greater in this
age group than for adults, which could be related to the greater
range of morbidities associated with age and the subsequent
use of medications to treat them.
Effects of Antibiotics on the Microbiota
Although the microbiota is generally stable within individuals
over time, the composition can be altered due to external pertur-
bations. One of the major factors that can perturb the composi-
tion of the microbiota is antibiotic use. Antibiotics have
a profound effect on the microbiota, and their overuse is linked
with an increase in antibiotic-resistant pathogens. There is now
compelling evidence of major alterations of the microbiota
following treatment with antibiotics (Dethlefsen et al., 2008; Jern-
berg et al., 2007; Sullivan et al., 2001). Although the particular
taxa affected vary among individuals, some taxa do not recover
even months after treatment, and in general, there is a long-term
decrease in bacterial diversity. As the established gut bacterial
community reshapes after treatment with antibiotics, there is
a reduced resistance to colonization, allowing foreign microbes
that can outgrow commensal bacteria to cause permanent
changes in the structure of the microbiota and varying states
of disease. The repeated use of antibiotics in humans has
been hypothesized to increase the reservoir of antibiotic-
resistant genes in our own microbiome (Sommer et al., 2009).
In support of this hypothesis, some European countries have
observed a reduction in the number of antibiotic-resistant
pathogens following a reduction in the number of prescribed
antibiotics (Goossens et al., 2005).
Interactions between the Host Immune System
and the Microbiota
Mammals have coevolved over millions of years with our micro-
biota (Ley et al., 2008). Thus it is not surprising that our immune
system, and especially the mucosal immune system, has devel-
oped an intricate connection with our associated microbiota.1262 Cell 148, March 16, 2012 ª2012 Elsevier Inc.It appears that both the innate and adaptive immune systems
have evolved to require microbial interactions during their
development (Chow et al., 2010; O’Hara and Shanahan, 2006).
Germ-free mice have reduced gut secretory IgA, defects in
development of gut-associated lymphoid tissues, and smaller
Peyer’s patches and mesenteric lymph nodes (Round and
Mazmanian, 2009). IgA in particular plays a fundamental role in
mucosal immunity, as it is induced in response to colonization
by specific commensal bacteria to protect mucosal surfaces
and contribute to host-microbiota mutualism (Bouskra et al.,
2008; Macpherson et al., 2011; Peterson et al., 2007).
Recognition of Commensal Microbes by the Immune
System
The innate immune system recognizes general microbe-associ-
ated molecular patterns (MAMPs) that are present across
diverse lineages of bacteria, such as components of the bacterial
cell wall (lipopolysaccharide and peptidoglycan) and flagellin.
Toll-like receptors (TLRs) are one of the several proteins that
the host uses to recognize such antigens. When TLRs are not
present or are mutated, the gut and mucosal immune systems
do not form normally (O’Hara and Shanahan, 2006). The
commensal bacteria appear to be important in suppressing
inflammatory response and promoting immunological tolerance,
and this interaction also occurs through TLRs (O’Hara and
Shanahan, 2006; Round et al., 2011). NOD-like receptors
(NLRs) also recognize microbial molecules and can form oligo-
mers (inflammasomes) that serve as sensors of damage-
associated patterns. Deficiency of NLPRP6, for example, results
in reduced IL-18 levels, an altered composition of themicrobiota,
and intestinal hyperplasia (Elinav et al., 2011).
Microbial Modulation of the Adaptive Immune System
The adaptive immune system is also programmed by the
commensal microbiota, and microbes have been shown to
impact the differentiation of T cell populations, which can be
not only determined by self-/non-self-discrimination mecha-
nisms but also educated by commensal microbiota (Lathrop
et al., 2011; Lee and Mazmanian, 2010). Commensal bacteria
are also capable of modulating the host innate immune system
to promote their own fitness in the intestinal niche. For instance,
Bacteroides thetaiotaomicron has been shown to induce
peptides with bactericidal activity that target other intestinal
microbes (Hooper et al., 2003). Being able to elicit low amounts
of IgA by modulating the immunodominant determinants has
also been proposed as a mechanism by which commensal
bacterial gain an advantage in the gut environment (Peterson
et al., 2007). One intriguing question is whether reduced eukary-
otic parasite load is increasing autoimmune disease incidence
by allowing immunological activity to be redirected, in a disrup-
tive way, in the absence of a coevolved engagement with
microbes (see discussion of the ‘‘hygiene hypothesis’’ below).
These examples demonstrate the impact of microbial interac-
tions with the immune systems on host health.
Disease and Dysbiosis
The characterization of the gut microbiota and its connections
to the host described so far have provided us an initial picture
of what might be a healthy state from a microbial perspec-
tive. The study of diseases, however, has been classically
approached from a ‘‘one microbe-one disease’’ viewpoint.
Viruses, eukaryotes, and bacteria were studied under conditions
in which they were believed to cause disease. However, just as
the ‘‘one gene-one enzyme’’ outlook proved to be an oversimpli-
fication that failed to explain complex phenotypes, we are now
starting to appreciate the fact that humans are colonized with
myriad viruses, eukaryotes and bacteria, and that some
diseases might result from dysbiosis rather than the presence
of a single disease-causing microbe. Examples of diseases
associated with microbial dysbiosis include autoimmune and
allergic diseases, obesity, inflammatory bowel disease (IBD),
and diabetes (Table 1).
The Obese Microbiota: Interactions with the Immune
System
Obesity is a physiological state that has emerged as a major
health concern in populations that have adopted a Western
diet and is closely tied to the microbiota (Ley, 2010). In animal
models of obesity, the interplay between the dominant gut phyla,
Bacteroidetes and Firmicutes, is shifted with a significant
reduction of the former and a corresponding increase in the
latter (Ley et al., 2005). The same trend is observed within indi-
vidual humans on weight-reduction diets (reviewed in Ley,
2010), although a study with human twins showed that in obese
individuals, the decrease in Bacteroidetes was accompanied
by an increase in Actinobacterium rather than in Firmicutes
(Turnbaugh et al., 2009a). The observed shift in the relative
abundances of these phyla results in an increased capacity for
harvesting energy from food and produces low-level inflamma-
tion. Several changes in host genetics and environmental factors
have been used to induce obesity in animal models and thus
provoke a change in microbiota composition. Remarkably, the
energy harvest phenotype is transmissible simply by transplant-
ing the obese microbiota into healthy, lean donors (Turnbaugh
et al., 2006, 2008). Zhang et al. suggest that increased energy
harvest in obese individuals is related to hydrogen transfer
between taxa as they observed a concurrent increase in both
hydrogen-producing Prevotellaceae and hydrogen-utilizing
methanogenic Archaea (Zhang et al., 2009).
Obesity results in a chronic state of low-level inflammation
very distinct from classical inflammation (Gregor and Hotamisli-
gil, 2011). This pattern includes moderate induction of inflamma-
tory cytokines such as TNF-a, IL-1b, and CCL2, as well as an
increase in mast cells, T cells, and macrophages (Gregor and
Hotamisligil, 2011). An increase in Bifidobacterium spp. has
also been shown to modulate inflammation in obese mice by
increasing the production of glucagon-like peptide-2, which
reduces intestinal permeability and thus reduces the transloca-
tion of lipopolysaccharides (Cani et al., 2009). Although the
elucidation of the exact mechanisms responsible for obesity is
still an open and complex problem, these studies demonstrate
the link between an imbalanced gut microbiota and diseased
states and suggest hypotheses to be tested in future research.
The importance of the interaction between the microbiota and
the immune system in obesity was demonstrated in a study
with genetically modified mice lacking TLR5, which recognizes
flagellin and is one of the major microbial receptors of the innate
immune system (Vijay-Kumar et al., 2010). These mice developcharacteristics of metabolic syndrome along with significant
changes in their gut microbiota, and it is hypothesized that the
alterations in the gut flora induce a low-grade inflammatory
signaling that eventually results in the development of metabolic
syndrome. Moreover, this obesity phenotype is transmissible
to wild-type mouse simply by transferring the microbiota
(Vijay-Kumar et al., 2010). A recent study, however, was unable
to reproduce some of these results, suggesting colony-specific
effects (Letran et al., 2011).
Crohn’s Disease
Crohn’s disease is a chronic gastrointestinal disorder with an
unknown etiology characterized by an inflammatory response
of the intestinal mucosa (Sartor, 2006). The development of
Crohn’s can only partly be described by genetics, with many of
the more than 99 polymorphisms associated with the disease
linked to the immune system and the recognition of microbes
(Anderson et al., 2011). Studies of twins discordant for Crohn’s
suggest that an environmental aspect is required for the devel-
opment of the disease (Halfvarson et al., 2006; Loftus, 2004).
An influential study by Cadwell et al. sheds light on how the
virome, genome, and microbiota might be interacting in the
development of Crohn’s disease (Cadwell et al., 2010). In this
study, Cadwell et al. used mouse lines with a hypomorphic
(HM) Atg16L1 gene (Cadwell et al., 2008), a gene associated
with susceptibility of developing Crohn’s (Hampe et al., 2007;
Rioux et al., 2007). It was found that the Paneth cells, epithelial
cells linked with mucosal immunity, of Atg16L1HM mice dis-
played abnormalities when infected with murine norovirus, but
wild-typemicemaintained normal Paneth cells despite infection.
This suggested that it was the combination of a virus and
a susceptible gene that resulted in Paneth cell abnormalities
(Ouellette, 2006; Vaishnava et al., 2008). Thus, the gut micro-
biota, in addition to the virome and host genetics, were shown
to play an important role in the etiology of a complex mammalian
disease.
Connections between Autoimmune Disorders
and the Microbiota
Further evidence for the importance of the microbiota in normal
immune function comes from the correlation between autoim-
mune diseases and the microbiota. In mouse models of type 1
diabetes, it has been shown that the interaction of the gut micro-
biota with the innate immune system modifies predisposition
toward developing diabetes (Wen et al., 2008). Compared with
non-autoimmune individuals, children at high genetic risk for
diabetes exhibit a distinct composition of the gut microbiota,
with decreased diversity over time and higher relative abun-
dances of Bacteroides ovatus and firmicute strain CO19 (Giongo
et al., 2011). Early results in animal models of multiple sclerosis
and rheumatoid arthritis also suggest a pronounced influence
of the gut microbiota. In animal models, these autoimmune
diseases do not develop in germ-freemice (Lee andMazmanian,
2010). In the case of multiple sclerosis models, the disease
phenotype is restored when germ-free mice are colonized by
specific bacterial taxa (Lee and Mazmanian, 2010). These auto-
immune diseases all result from inappropriate action of the
adaptive immune system mediated by the gut microbiota.Cell 148, March 16, 2012 ª2012 Elsevier Inc. 1263
Figure 2. Effect of Interactions of Bacteria, Viruses, and Eukaryotes in Health and Disease
Diseases have been traditionally studied under a paradigm of ‘‘one microbe, one disease.’’ However, a new understanding is emerging on how disease
phenotypes are actually a result of complex interactions between bacteria, viruses, and eukaryotes, as well as their interactions with the host or with certain
drugs. Virulence of some eukaryotes is, for instance, linked to the presence of certain bacteria, such as in the case of E. histolytica and E. coli or S. dysenteriae.
The susceptibility of the host to viral infections is conditioned by the particular configuration of the microbiota, whereas herpesvirus infection can confer
resistance to certain bacterial infections. Antibiotics can significantly reshape the composition of the microbiota. As a clear correlation has been observed
between many diseases and dysbiosis, the widespread use of antibiotics may be linked to the dramatic increase observed in autoimmune diseases over the last
years. Conversely, helminthes confer resistance to autoimmune diseases.Introduction of bacterial polysaccharides from the commensal
Bacteroides fragilis protects against the development of these
autoimmune diseases (Lee and Mazmanian, 2010).
Complex Microbial Interactions in Disease
So far we have mostly described the effect of imbalances in the
microbiota in health and some of the molecular mechanisms
linking bacterial, eukaryotic, or viral communities with disease.
However, complex diseases are rarely caused by a single
factor, and understanding how different elements interact to
induce a disease phenotype is crucial to facilitate prediction
and treatment of such states (Figure 2). Recent studies have
provided a number of examples of such complex, influential
interactions. For example, although herpesvirus can cause
acute disease, latent herpesvirus infection has been shown to
protect mice against the bacterial pathogens Listeria monocy-
togenes and Yersinia pestis by stimulating increased levels of
interferon-g and tumor necrosis factor (Barton et al., 2007).
The resulting basal level of immunity stimulation suggests
that lifelong latency of herpesvirus might have been evolution-
arily beneficial, resulting in a symbiotic host-virome relationship
that promotes host health (Barton et al., 2007). Future therapies
may thus involve the active modulation of viral and microbial1264 Cell 148, March 16, 2012 ª2012 Elsevier Inc.communities in the context of genome susceptibility to combat
disease states.
Helicobacter pylori provides a second example of how the
interaction between members of the microbiota and the host
can have a major impact in health. A Gram-negative pathogen
linked with gastric ulcers and stomach cancer, H. pylori has
been associated with humans for at least 58,000 years, although
most of us carry it asymptomatically (Linz et al., 2007). Infection
by H. pylori is intriguingly correlated with respiratory diseases
such as chronic obstructive pulmonary disease (COPD) and
pulmonary tuberculosis (Roussos et al., 2006). The evidence is,
however, contradictory on the nature of this correlation: some
studies show an increased risk of developing diseases in
subjects infected by H. pylori (Roussos et al., 2002), but recent
work by Perry and colleagues observed the opposite effect,
where H. pylori confers protection against tuberculosis (Perry
et al., 2010). In this study, H. pylori seropositive subjects with
latent tuberculosis had higher tuberculosis antigen-induced
IFN-g responses and enhanced Th1-like responses than those
not carrying H. pylori. Monkeys infected with H. pylori were
less likely to develop tuberculosis than uninfected animals.
Although the mechanism is unclear, infections early in life could
result in differentiation of immature T cells to a Th1-like
phenotype, thus promoting a protective immune response.
Alternatively, H. pylori could induce a continuous innate
response from the host, providing incidental protection against
other pathogens.
Consequences of Disrupted Host-Microbiota
Interactions
In our modern environment, many people are not exposed to the
microbiota of our evolutionary past. In the absence of appro-
priate microbial signals, the immune system does not develop
normally (Round and Mazmanian, 2009). Autoimmune diseases
in general, and allergies in particular, have significantly increased
in developed countries over the last few years, which has been
attributed to a burgeoning list of potential factors. The hygiene
hypothesis postulates that lack of exposure to pathogenic and
nonpathogenic microbial products early in life might result in
an asthmatic phenotype due to an impaired development of
the immune system (Strachan, 1989). Under this hypothesis,
the fact that developing countries have lower rates of allergies
could be due to larger family sizes, a larger percentage of the
population living in rural environments with poor sanitary condi-
tions, lower antibiotic use, and prevalence of helminths.
A potential mechanism that has been proposed to support
the hygiene hypothesis is the counter-regulatory role of inter-
leukin-10 (IL-10) (Wills-Karp et al., 2001). IL-10 is an anti-inflam-
matory cytokine that downregulates responses from both the
innate and adaptive immune systems. Infection by microbial
organisms results in the upregulation of IL-10, which subse-
quently suppresses inflammation and a predisposition to
allergies. A reduced exposure early in life to infectious agents
and human-resident mutualists could result in a weakened
machinery for counter-regulation of inflammatory responses
and therefore to an increase in the prevalence of allergies.
Although different genes can predispose individuals to allergic
diseases (see, for instance, Moffatt et al., 2007 and references
within), it is the interaction of these polymorphic genes with their
environment that seems to be producing the most encouraging
results. For instance, elevated serum IgE levels (a marker for
atopy) have been associated with a single-nucleotide polymor-
phism (SNP) in the promoter region of CD14, a coreceptor for
lipopolysaccharides (Vercelli, 2003). However, children carrying
the polymorphism who have regular contact with pets have
higher levels of serum IgE, whereas the opposite effect is
observed for those in contact with stable animals (Eder et al.,
2005). Parasites such as worms also induce the production of
IgE, and it is suggested that the general absence of parasites
in Western populations is a factor that contributes to the inap-
propriate immune response to allergens. In support of this
hypothesis, there is anecdotal evidence that taking hookworm
eggs reduces or eliminates allergic responses (Feary et al.,
2011).
Evidence from H. pylori also points to consequences of dis-
rupting the microbiota we have coevolved with over millennia
(Blaser, 2011). Gastric colonization by H. pylori usually takes
place within the first 10 years of life and can persist throughout
life in the absence of antibiotics (Brown, 2000; Perry et al.,
2006). Nearly all adults in developing countries harbor
H. pylori, and this was likely true for humans in general formost of our evolutionary history. Interestingly, there is strong
evidence linking the decreased prevalence of H. pylori in the
Western world to increased antibiotic use and to the elevated
rates of asthma and allergic disorders in this same population
(Anderson, 2005; Banatvala et al., 1993). Moreover, increased
prevalence of gastresophageal reflux disease (GERD), adeno-
carcinoma of the esophagus, and Barrett’s esophagus has
been linked to decreased prevalence of cagA+ strains of
H. pylori (reviewed in Atherton and Blaser, 2009). Overall, the
strong link between H. pylori and modern diseases illustrates
how the disruption of the human microbiota can have dire health
consequences.
Interplay between Bacteria and Eukaryotes
The interplay between eukaryotes and bacteria in the gut is likely
to be an important factor in understanding the variation in viru-
lence that is observed across pathogenic taxa. Most diseases
associated with eukaryotic parasites exhibit a range of pathoge-
nicity in the human host, from severe symptoms or death to
asymptomatic infections (e.g., Pritt and Clark, 2008). Some of
this range may be due to variation in the microbial community
of the host, in addition to host immune factors and variation
between strains (Cox, 2001). The importance of such interac-
tions has already been demonstrated for some species in the
context of the overall bacterial community, though interactions
between one eukaryote and one bacteria have received more
attention thus far. The bacterial community in the gut is known
to have an impact on the proliferation and pathogenicity of the
Giardia parasite in mice and humans. For example, the presence
of Lactobacillus slows the growth of Giardia (Mu¨ller and von
Allmen, 2005). Community-wide differences in the microbiota
result in isogenic strains of mice being either susceptible or
resistant to pathogenic Giardia infections, and this difference is
erased when the mice are treated with antibiotics (Mu¨ller and
von Allmen, 2005). A further example of bacteria altering viru-
lence comes from Entamoeba histolytica cultured with and
without pathogenic strains of Escherichia coli and Shigella
dysenteriae (Galva´n-Moroyoqui et al., 2008). E. histolytica lives
in the lumen of the gut in 90% of cases and does not cause
symptomatic infections, however the remaining 10% of infec-
tions are characterized by invasive amoebiasis (ameobic dysen-
tery), and this fraction is the second leading cause of mortality
due to eukaryotic infections after malaria. Thus, understanding
the factors that result in epithelial invasion is crucial. Entamoeba
was shown to bemuchmore likely to become invasive and cause
damage to epithelial cells in the presence of pathogenic E. coli
and S. dysenteriae (Galva´n-Moroyoqui et al., 2008).
Some eukaryotic taxa have been shown to be intimately
associatedwith bacteria in the form of endosymbioses, including
Trichomonas vaginalis (Rappelli et al., 2001), Giardia (Nemanic
et al., 1979), and Entamoeba (Ahmad, 1971). Trichomonas
vaginalis is a major vaginal pathogen infecting 180 million people
worldwide each year and causes vaginal inflammation as well
as problems with pregnancy (Soper, 2004). In the case of
Trichomonas, the bacterial endosymbiont is itself a pathogen,
Mycoplasma hominis (Rappelli et al., 2001). This association
leads to coinfection, and infected Trichomonas cells can transfer
Mycoplasma directly to human epithelial cells (Rappelli et al.,Cell 148, March 16, 2012 ª2012 Elsevier Inc. 1265
2001). Infection with Trichomonas also increases the likelihood
of contracting other infections, including bacterial vaginosis
and HIV (Soper, 2004), highlighting the importance of including
eukaryotes in vaginal microbial studies. One study also hints
that bacteria mediate the immune response to Giardia as only
Giardia cells harboring bacterial endosymbionts are targeted
and destroyed by Paneth cells, although the mechanism for
this effect remains unclear (Mu¨ller and von Allmen, 2005).
Future Directions
Restoring Microbial Health
As we have seen in previous sections, disease states are often
correlated with imbalances in the gut microbiota. Restoring
a healthy microbial community by transplantation of a foreign
gut microbiota has proven to be a valuable tool in the treatment
of certain diseases (Bakken, 2009) and also allows the impact of
the microbiota in determining phenotype to be tested. Trans-
plant experiments that establish that the state can be recaptured
by transmitting the microbiota can be used to further support
the hypothesis that changes in the microbiota are a driving force
in disease progression. For instance, obesity and several
disease phenotypes induced by changes in host genetics cause
dysbiosis in the gut. Remarkably, these phenotypes can be
transferred to germ-free wild-type hosts simply by inoculating
them with the microbiota from the diseased donors (Turnbaugh
et al., 2006; Vijay-Kumar et al., 2010; Wen et al., 2008). Further-
more, transplantation from a healthy to a diseased individual
can help in recovering microbial balance in the gut. Khoruts
et al. showed how transplanting the microbial community from
a healthy donor to a patient suffering from Clostridium difficile-
associated disease (CDAD) significantly modified the bacterial
composition in the patient (Khoruts et al., 2010). After 2 weeks,
the microbiota of the recipient had dramatically changed from
a Firmicutes- and Bacteroidetes-deficient configuration to
a community highly similar to that of the donor, dominated by
Bacteroides spp. This radical shift in the composition of the
microbiota was also accompanied by the disappearance of the
symptoms associated with CDAD in the patient.
The conditions for a successful transfer of an exogenous
microbiota are, however, not yet well understood. The deep
influence that antibiotics exert on the microbiota can be used
to artificially manipulate the bacterial communities in the gut,
in the hope that such manipulation will allow for a smoother
transplantation of microbiota from a donor. Manichanh et al.
tested whether the use of antibiotics prior to transplantation
would facilitate the colonization process by reducing bacterial
load (Manichanh et al., 2010). Somewhat counterintuitively,
antibiotics did in fact not help increase the establishment of
donor phylotypes, suggesting that the establishment of trans-
planted microbiota may be more difficult to achieve than
initially thought. Antibiotic-manipulated mice models are attrac-
tive as an inexpensive substitute for germ-free animals, but
additional work is required to determine whether they can
play this role effectively. For example, uneven impacts of anti-
biotics on the gut microbiota may complicate the interpretation
of studies that simulate germ-free mice by giving conventionally
raised mice antibiotics. Determining how to facilitate transplan-
tation, what donors are more compatible with the patient, or1266 Cell 148, March 16, 2012 ª2012 Elsevier Inc.what risks might be involved in this procedure remains an
open problem in this field.
Characterizing the Global Microbiota
Most studies of the microbiota so far have only characterized
individuals under a Western diet (Peterson et al., 2009; Qin
et al., 2010). Given the observed interpersonal variability in the
composition of microbial communities, it is reasonable to
assume that the microbiota of non-Western-diet populations
will most certainly exhibit notable differences. For example,
Japanese individuals are unique in harboring an enzyme
acquired from a marine bacterium to help in the digestion of
seaweed, which is prevalent in the Japanese diet (Hehemann
et al., 2010). Differences in diet between children in Africa and
Europe have also been shown to correlate with differences in
the microbiota, with the African cohort being enriched in Bacter-
oidetes and depleted in Firmicutes, presumably to maximize
energy uptake from their fiber-rich diet (De Filippo et al., 2010).
It will therefore be important to characterize the full microbiota
from geographically and socioeconomically diverse populations
to establish the ‘‘normal’’ human microbiota. The global trend
toward a Western-like diet, with its high intakes of red meat,
high-fat food, and sugars, will likely result in a homogenization
of the microbial communities harbored by different populations
and perhaps the loss of ‘‘endangered microbes’’ that could
play important roles in bacteriotherapy (Blaser, 2011).
Events that Alter an Individual’s Microbiota
We also argue that there is a need for more complete time-series
analysis of microbial communities at higher resolution and longer
time ranges to assess normal variability and variation that is
associated with disturbance events such as antibiotic use or
diet shifts. Detailed time series of healthy individuals should yield
better understanding of both the normal levels of variability
through time and what amounts of change the microbiota can
withstand before becoming diseased. These studies may
include seemingly benign events such as cohabitation (does it
change your microbiota, and if so does it affect men or women
more significantly?) or fine-scale characterization to determine
whether there is a ‘‘morning’’ versus ‘‘night’’ microbiota to inform
the suggested timing of therapies.
Studies before and after events that perturb the microbiota,
such as diet shifts, antibiotic use, surgery, drug treatments, or
transplantations, will be key to assessing the impact of such
events.
As discussed above, antibiotics have a noticeable, lasting
effect in the composition of microbial communities (Dethlefsen
et al., 2008; Jernberg et al., 2007; Sullivan et al., 2001). The
microbiome can also interact with drugs and influence the way
our bodies perceive drugs (reviewed in Gonzalez et al., 2011).
Additionally, given our currently incomplete understanding of
how the interactions of the microbiota can result in the develop-
ment of diseases, it will be increasingly important to characterize
all aspects of human-associated microbial communities,
including multiple taxa and their dynamics, in disease pheno-
types.
Conclusion
Taken together, the findings we have reviewed suggest that in
order to further advance our understanding of health and
disease, we will require an improved characterization of the
variability in the microbiota, a better understanding of how
such variability can result in similar or different functional profiles,
and more integrative studies that take into account the interac-
tion between the microbiota, the host, and the environment to
produce a phenotype. An increasing variety of disease states
and disorders are being found to correlate with the host micro-
biota (recently reviewed in Virgin and Todd, 2011), including
susceptibility to influenza (Ichinohe et al., 2011), retrovirus trans-
mission (Kane et al., 2011), colon cancer (Kostic et al., 2011),
autoimmune demyelination (Kostic et al., 2011), and even
behavior (Heijtz et al., 2011; Vijay-Kumar et al., 2010). Large-
scale sequencing projects such as the Human Microbiome
Project (Peterson et al., 2009; Turnbaugh et al., 2007) and the
Earth Microbiome Project (Gilbert et al., 2010) will ultimately be
critical for providing a unified and all-encompassing view to
better understand the link between the microbiota and health.
Transforming the vast amounts of data that these projects will
generate into useful and applicable knowledge requires novel
approaches such as machine learning. The application of these
methods will hopefully more accurately predict disease states
and appropriate therapies by making use of larger numbers of
samples across populations and over time (Knights et al., 2011).
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